Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26876,126,1.19 [0.98-1.45],0.0787765762174583
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27635,207,1.02 [0.88-1.19],0.7759856425481992
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27355,1366,1.07 [1.01-1.14],0.0210416229751979
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,27661,481,1.07 [0.97-1.19],0.1694033708802058
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26800,3559,1.06 [1.03-1.10],0.0010529077136891
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27027,2916,1.05 [1.01-1.10],0.0114093742883217
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27372,1384,1.07 [1.00-1.13],0.0337496650736851
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27554,92,1.17 [0.94-1.47],0.1671804423675526
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25779,832,1.08 [1.00-1.17],0.0420021837633302
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24932,976,1.10 [1.03-1.18],0.007191882357571
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,24949,265,1.09 [0.95-1.25],0.1964182457416939
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19409,1699,1.09 [1.03-1.15],0.0024910454875544
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24715,382,1.10 [0.98-1.23],0.0907547596323287
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27601,1613,1.05 [0.99-1.11],0.0810939643819352
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,27727,547,1.10 [1.00-1.21],0.0482653344766804
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26962,973,1.09 [1.01-1.17],0.0208849791572953
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27671,921,1.09 [1.01-1.17],0.0208191276498167
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26195,207,1.02 [0.88-1.20],0.7543729726207312
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27791,45,1.15 [0.83-1.60],0.3919282892651939
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27554,804,1.07 [0.99-1.16],0.095817356294654
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27545,83,1.00 [0.79-1.28],0.9844763906609996
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27690,198,1.21 [1.04-1.41],0.015676524751696
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27672,180,1.16 [0.98-1.36],0.0763193952994526
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26336,347,1.14 [1.01-1.28],0.0316538091850574
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26259,270,1.02 [0.89-1.17],0.7661652848193634
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26117,129,1.12 [0.93-1.36],0.2401233783642948
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27767,38,1.02 [0.71-1.46],0.9045190795702284
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27715,165,1.03 [0.86-1.22],0.7756470582395946
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral warts,27600,50,1.14 [0.84-1.55],0.4046510508655455
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27630,80,1.07 [0.84-1.37],0.582027014694279
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,27518,246,1.04 [0.90-1.19],0.6265457641772789
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27687,71,1.09 [0.84-1.41],0.5291588065005641
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27681,72,1.22 [0.94-1.58],0.1276251770809837
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27503,1237,1.01 [0.95-1.07],0.795443798007624
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of meninges,27765,82,1.24 [0.97-1.57],0.0820409638245997
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27722,67,1.16 [0.89-1.51],0.2827711553792911
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27757,137,1.09 [0.91-1.32],0.3459238458239342
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of ovary,27708,179,1.04 [0.89-1.23],0.6128853280115039
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27769,278,0.95 [0.83-1.08],0.4153192745437077
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Caecum,27775,254,0.91 [0.79-1.04],0.173596638071173
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27703,63,0.93 [0.70-1.23],0.5899301611699356
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,27773,158,0.83 [0.69-1.00],0.045532541100691
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,27735,278,1.04 [0.91-1.19],0.5515872094339936
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27685,506,0.97 [0.88-1.07],0.5529848280902488
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27770,301,0.95 [0.83-1.08],0.3939878956982464
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Carcinoma in situ of breast,22518,139,0.82 [0.68-0.99],0.0420745125030138
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22609,170,0.95 [0.80-1.13],0.5795935572102504
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22588,34,1.04 [0.71-1.52],0.8394459217484086
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22621,67,1.03 [0.79-1.36],0.8173935779843957
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27721,139,0.85 [0.70-1.03],0.0932903763765142
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma, any site",27722,137,0.85 [0.70-1.03],0.0914932577442719
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Leiomyoma of uterus,26791,593,0.96 [0.88-1.05],0.3852797481742012
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Lung cancer and mesothelioma,19921,314,0.97 [0.86-1.10],0.6740555083580867
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Lymphoid leukaemia,22592,38,1.06 [0.74-1.53],0.7327206750484176
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22732,178,0.99 [0.84-1.17],0.8985489804686866
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22670,116,0.97 [0.79-1.20],0.7991854961192877
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22739,185,0.89 [0.76-1.05],0.1832982102796516
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22626,72,1.17 [0.90-1.52],0.2329693024774825
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22627,73,1.18 [0.91-1.52],0.211069632844316
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22612,58,1.02 [0.76-1.37],0.8820049279797896
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22696,142,1.02 [0.84-1.23],0.8536346925978541
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22660,106,1.14 [0.92-1.41],0.2294528138318164
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22641,87,1.11 [0.88-1.41],0.367969719791358
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22597,43,1.26 [0.90-1.75],0.1771820506897816
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22636,82,0.78 [0.61-1.01],0.0586472031179881
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi,27520,230,1.08 [0.94-1.25],0.2686079210205826
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi of trunk,27742,81,1.02 [0.80-1.30],0.8662372815174184
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanoma in situ,22589,89,1.13 [0.89-1.43],0.3055569164814994
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22637,83,1.06 [0.83-1.35],0.6402484054777955
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22711,157,1.10 [0.92-1.31],0.2930449666710437
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22785,231,0.88 [0.76-1.02],0.0901166330163665
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22652,98,1.22 [0.98-1.52],0.0794181607140017
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Other benign neoplasms of skin,27563,173,0.98 [0.82-1.15],0.7685031892025589
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23513,959,0.98 [0.91-1.05],0.540780100730319
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23553,999,0.98 [0.91-1.05],0.5362102118525904
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27479,378,0.99 [0.88-1.11],0.851847049664306
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25737,107,1.18 [0.95-1.46],0.1294275064431321
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27171,70,1.18 [0.91-1.54],0.2051880395540006
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26757,3018,1.10 [1.05-1.14],7.076519947261677e-06
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26121,36,0.98 [0.67-1.43],0.9104432777927964
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27374,46,1.45 [1.06-1.98],0.0198497225771076
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27196,1566,1.11 [1.05-1.17],0.0003261148642361
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27196,1566,1.11 [1.05-1.17],0.0003261148642361
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25701,71,0.98 [0.75-1.28],0.9011664537470446
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27370,1285,1.17 [1.10-1.24],3.580795028679155e-07
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27452,124,0.88 [0.72-1.08],0.2313059458553497
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27155,54,1.19 [0.89-1.61],0.242085398417823
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27159,58,1.09 [0.81-1.45],0.5772967741939176
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27568,240,1.02 [0.89-1.18],0.7560495838375878
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27674,63,1.27 [0.97-1.66],0.0858293895319392
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27531,203,0.89 [0.76-1.04],0.132069658487201
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26221,136,1.26 [1.05-1.52],0.0146361782531298
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,22363,264,1.08 [0.94-1.24],0.2771184907781785
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26346,69,1.08 [0.83-1.40],0.5638986450262339
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26340,63,1.16 [0.86-1.55],0.3304123016424249
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,22152,53,1.32 [0.99-1.77],0.0610090051599042
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25495,72,1.15 [0.89-1.49],0.2732393690051667
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25120,246,1.00 [0.86-1.15],0.9629273715077952
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27347,516,0.94 [0.85-1.04],0.2561998907009827
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27120,289,0.97 [0.85-1.11],0.6454658714237758
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,26920,89,1.12 [0.88-1.41],0.3552258757023283
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27387,1964,1.06 [1.01-1.11],0.0259595024483928
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24581,1910,1.07 [1.02-1.12],0.0104989552463021
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",22159,60,1.23 [0.93-1.62],0.1527392322738443
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24633,118,1.02 [0.83-1.25],0.8492564235562212
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,22386,287,1.06 [0.93-1.21],0.3489124195374307
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,22146,47,1.29 [0.94-1.76],0.1108533217499911
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25287,3188,1.09 [1.05-1.13],1.2644861157674192e-05
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,22301,202,1.01 [0.86-1.18],0.9340856977139224
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22642,543,1.07 [0.97-1.17],0.1749330586564315
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27687,375,1.22 [1.09-1.36],0.0006052442385427
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27499,187,1.26 [1.08-1.48],0.0035513574525258
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,22202,103,0.90 [0.72-1.13],0.364134422151357
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",22155,56,1.06 [0.79-1.42],0.7149548944187039
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26883,2368,1.05 [1.01-1.10],0.0212242783661166
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,22314,215,1.11 [0.96-1.29],0.1634078744942628
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,22319,220,1.23 [1.06-1.43],0.0058797079585466
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22637,538,1.07 [0.98-1.18],0.1392835556070765
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,22194,95,1.08 [0.86-1.36],0.5054534822903619
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27489,177,1.23 [1.05-1.45],0.0113607545786179
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22740,641,1.00 [0.92-1.10],0.943773536353545
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22664,565,1.02 [0.93-1.12],0.6351172545821924
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,24942,68,1.09 [0.84-1.42],0.5245348337055762
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26861,4762,1.08 [1.05-1.12],8.710784428729072e-07
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24593,78,0.98 [0.76-1.26],0.8882103679732972
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24603,88,0.98 [0.77-1.24],0.8696758931654625
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27587,2112,1.01 [0.96-1.06],0.6543256297171414
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27592,2111,1.01 [0.96-1.06],0.6398701971091023
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24597,82,1.10 [0.86-1.40],0.4403966224540114
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27373,1613,1.06 [1.01-1.12],0.0269000439751749
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23652,1553,1.06 [1.00-1.12],0.0333008815911469
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27776,193,1.06 [0.91-1.25],0.4566175211829568
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,26888,57,1.10 [0.82-1.47],0.5364984984383431
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,25893,133,0.97 [0.80-1.18],0.7856560994936093
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,25964,204,1.16 [0.99-1.35],0.0651685975188815
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",22368,269,1.23 [1.08-1.40],0.0023652297051326
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25927,141,1.10 [0.91-1.32],0.3197357744099907
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1735,50,0.92 [0.67-1.27],0.6150230924937863
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1850,189,1.13 [0.96-1.33],0.1493379202214818
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25813,27,1.46 [0.96-2.22],0.0755227092797275
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1717,33,1.14 [0.77-1.69],0.5037349718369537
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27295,1509,1.11 [1.05-1.17],0.0003498197144968
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27174,343,0.93 [0.82-1.05],0.2436535053377052
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25363,489,1.05 [0.95-1.17],0.2957866545663739
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22844,745,1.09 [1.01-1.18],0.0367122117435293
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27690,236,0.95 [0.82-1.09],0.4555398937300844
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26759,56,0.94 [0.70-1.27],0.6929936271731173
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,26235,901,1.11 [1.03-1.19],0.0072347030162541
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26803,100,0.85 [0.68-1.07],0.1656764695085059
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26739,36,1.23 [0.86-1.77],0.2598436910010641
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26856,153,1.06 [0.88-1.26],0.5396682564061146
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18059,1503,1.04 [0.98-1.11],0.1513955271317697
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,AV-block,24323,246,1.10 [0.96-1.27],0.1723782550611766
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27747,307,0.86 [0.76-0.98],0.0269076459579492
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,16688,132,1.40 [1.17-1.69],0.0003347352436237
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24215,138,0.87 [0.72-1.05],0.1439638260032473
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",24159,82,1.01 [0.79-1.29],0.950550485692147
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27786,35,1.02 [0.70-1.49],0.928962344677367
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,24821,744,1.06 [0.97-1.15],0.1807081043847117
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26850,1528,1.08 [1.02-1.14],0.0087543187364645
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24965,7351,1.05 [1.02-1.08],0.0001568427459126
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26253,251,0.99 [0.86-1.14],0.8582583094640803
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Endocarditis,24139,62,1.20 [0.91-1.58],0.1966744123104244
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27688,875,1.12 [1.04-1.20],0.0036956910119317
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertension,25598,6214,1.05 [1.02-1.08],0.0003481018535702
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25611,6227,1.05 [1.02-1.08],0.0003608691008495
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27675,46,0.86 [0.61-1.20],0.3744243669331097
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19555,171,1.07 [0.90-1.27],0.4586965281752624
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19492,108,1.50 [1.22-1.84],0.0001061764190557
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypotension,27645,1123,1.00 [0.94-1.07],0.9879423942091962
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27016,94,1.11 [0.88-1.39],0.3740021247487437
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27055,1721,1.09 [1.03-1.15],0.0015575901561534
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27470,466,1.04 [0.94-1.15],0.4713234882073144
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,24382,305,1.01 [0.89-1.15],0.8369805913660633
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27561,617,1.07 [0.98-1.17],0.1457834761620523
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25830,496,1.09 [0.99-1.21],0.0778153571141519
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27764,89,1.23 [0.98-1.55],0.0731866307794691
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27782,247,1.09 [0.94-1.25],0.2429376579967017
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,26041,39,1.00 [0.70-1.43],0.9948661369135148
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other aneurysm,26763,60,0.88 [0.66-1.17],0.3827787048427847
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,24438,361,1.02 [0.91-1.15],0.7542994102493226
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26772,69,1.28 [0.99-1.66],0.056671223059525
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26901,198,0.99 [0.84-1.16],0.885367414917386
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,24235,158,0.96 [0.80-1.14],0.6184494737111698
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,26098,96,1.01 [0.81-1.27],0.9038761775168234
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26047,45,1.25 [0.91-1.73],0.1682719160108348
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26520,39,0.75 [0.52-1.09],0.1334671182012522
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26166,164,1.03 [0.86-1.23],0.7422258236482164
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24897,820,1.02 [0.95-1.11],0.5373655798173093
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26567,45,0.89 [0.64-1.25],0.501809661699369
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27213,510,1.00 [0.91-1.10],0.9831309072590771
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27209,331,1.06 [0.94-1.20],0.3531891441336819
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27027,546,0.99 [0.90-1.09],0.8395410687599012
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16851,295,1.03 [0.91-1.17],0.6305002515054587
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26969,280,1.03 [0.91-1.18],0.6248609686014157
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26335,333,1.04 [0.92-1.18],0.4994336390090294
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27325,447,1.11 [1.00-1.23],0.0538519237642225
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27711,599,1.04 [0.95-1.14],0.4026157648635871
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,24305,228,1.06 [0.92-1.23],0.4352147793723599
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27200,322,1.07 [0.94-1.21],0.3090349177019613
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26643,162,0.91 [0.76-1.09],0.3076377272163766
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27463,541,1.04 [0.95-1.15],0.3758194857055227
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27437,587,1.03 [0.94-1.13],0.5044367714618492
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,26983,69,1.01 [0.78-1.32],0.918216910231062
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26750,47,0.91 [0.66-1.26],0.5749313070968753
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27224,220,1.08 [0.93-1.25],0.3074055132345629
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27150,206,1.14 [0.98-1.33],0.0983531234289179
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Varicose veins,26470,468,1.03 [0.93-1.14],0.6056557253783947
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26715,97,0.97 [0.77-1.21],0.7811458103029189
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27575,714,1.08 [0.99-1.17],0.0764357433801181
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27743,220,1.05 [0.91-1.22],0.5017575105034691
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24687,1881,1.06 [1.01-1.12],0.0183626583919658
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Any mental disorder,27167,4361,1.06 [1.02-1.09],0.0016615839345349
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27711,261,1.04 [0.91-1.19],0.5555155063392492
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24789,1983,1.07 [1.02-1.13],0.006382019592131
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22903,97,1.02 [0.81-1.28],0.8791036883481603
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Smoking dependency,27370,1210,1.06 [1.00-1.13],0.0643097974243427
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24200,1394,1.06 [0.99-1.12],0.0737889776471815
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Vascular dementia,27281,103,0.94 [0.75-1.18],0.6003591083498013
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Alzheimer disease,27791,361,1.00 [0.89-1.13],0.9551810353613068
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",18977,58,1.00 [0.74-1.34],0.9812880897136949
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Bell's palsy,25594,85,1.02 [0.80-1.30],0.8648407206467059
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26155,646,1.02 [0.94-1.12],0.6046106272074809
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral cysts,27380,225,1.09 [0.94-1.26],0.2617253217674564
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27714,280,0.97 [0.85-1.11],0.6349575190683129
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27298,41,0.98 [0.69-1.39],0.9142674054993116
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27776,47,1.35 [0.99-1.84],0.0615256718154852
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27210,55,0.90 [0.66-1.22],0.4938839006644012
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Epilepsy,26282,285,1.02 [0.89-1.16],0.773127387255043
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27365,1368,1.03 [0.97-1.10],0.3010380730207209
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27744,525,1.04 [0.94-1.15],0.4209133775185786
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27138,2943,0.98 [0.94-1.02],0.4032773357601947
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,27415,48,1.18 [0.86-1.61],0.3111972165841031
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hemiplegia,27656,222,1.01 [0.87-1.18],0.8544468762297612
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hydrocephalus,27218,63,1.11 [0.84-1.46],0.4542645314990551
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27770,77,1.18 [0.92-1.52],0.1821034221371974
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25635,126,0.98 [0.80-1.19],0.8281759391626905
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25575,66,1.11 [0.85-1.45],0.4555075678652482
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Memory loss,27153,95,1.01 [0.80-1.27],0.9472977986317588
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Migraine,26516,519,1.04 [0.94-1.15],0.41938725235433
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27673,467,1.02 [0.92-1.13],0.6883112730017327
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Motor neuron disease,19067,122,0.99 [0.81-1.21],0.935388203278722
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27566,141,1.00 [0.83-1.20],0.9591789739571434
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26925,1416,1.05 [0.99-1.11],0.139596369821658
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Neurological diseases,26151,3853,1.03 [0.99-1.07],0.121256121675602
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27419,162,0.99 [0.83-1.18],0.87061440902187
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25942,433,1.10 [0.99-1.23],0.0673137000447038
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27732,241,1.11 [0.96-1.28],0.150004961487334
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22381,670,1.00 [0.92-1.09],0.9801352974958109
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27223,68,1.07 [0.82-1.40],0.6098682402135192
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27282,127,0.89 [0.73-1.09],0.2745260091483078
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27409,190,1.13 [0.96-1.33],0.1298789136810913
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25604,95,1.04 [0.83-1.31],0.7291199645573143
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other headache syndromes,26073,76,1.20 [0.94-1.55],0.1440090221505946
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,27668,513,1.06 [0.96-1.17],0.263610673113697
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,26409,412,0.98 [0.88-1.09],0.6701634293546744
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Parkinson's disease,27768,318,0.95 [0.84-1.08],0.4684288899050257
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27240,85,1.19 [0.94-1.51],0.1430344384651362
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,27789,105,1.07 [0.86-1.32],0.562736864702228
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,27608,325,0.98 [0.87-1.11],0.7548483903978485
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27533,42,1.31 [0.95-1.82],0.1046411275558314
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27780,151,0.93 [0.77-1.11],0.4245782883402
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25577,68,1.03 [0.78-1.34],0.8551613625749573
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27791,365,1.01 [0.89-1.13],0.9181448726487602
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27237,100,0.95 [0.76-1.19],0.6467411876759797
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27195,112,0.92 [0.74-1.14],0.4396748317760989
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27315,484,1.03 [0.93-1.14],0.5776535123465777
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27641,174,1.13 [0.96-1.34],0.1497845793336269
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26662,63,1.14 [0.86-1.50],0.3639244799172075
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26651,52,1.18 [0.87-1.59],0.2903617778892322
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27668,57,1.23 [0.92-1.64],0.1633359678608451
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27496,166,1.04 [0.87-1.23],0.6763238876959139
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1724,39,1.30 [0.91-1.84],0.1483760033599339
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2072,74,0.93 [0.72-1.21],0.6090608879766015
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27173,90,0.90 [0.71-1.14],0.3723642271318446
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27603,1074,1.05 [0.99-1.13],0.1257585948780941
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27366,767,1.00 [0.92-1.08],0.917372221414066
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26900,301,1.00 [0.88-1.14],0.99660085266269
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27695,864,1.02 [0.95-1.10],0.5478446746421668
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27774,70,1.04 [0.79-1.35],0.7955184185882992
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27617,786,1.03 [0.95-1.11],0.4690232161166199
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27744,414,1.02 [0.91-1.14],0.7335176227836132
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27694,210,0.95 [0.81-1.10],0.4877581613956686
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26640,41,1.05 [0.74-1.48],0.8044861315846055
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26649,50,1.20 [0.88-1.63],0.2537655810788353
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26665,66,0.89 [0.67-1.17],0.4063866148793877
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27695,726,0.99 [0.92-1.08],0.905077700250288
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27155,186,0.95 [0.81-1.12],0.5621680496584265
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,26900,69,1.10 [0.84-1.43],0.5013288456116041
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27436,106,1.02 [0.82-1.26],0.8719875437926174
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27647,317,1.01 [0.90-1.15],0.8167960052038961
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27046,215,1.00 [0.86-1.16],0.996225650525187
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27621,137,0.92 [0.76-1.12],0.4185129400260239
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27446,477,1.02 [0.92-1.13],0.7621065047450541
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27236,153,1.00 [0.83-1.19],0.9702785460348204
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,25975,2551,1.04 [0.99-1.09],0.0861348387403594
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27606,276,1.02 [0.89-1.17],0.766265895654145
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27764,160,1.10 [0.92-1.30],0.3017826575105001
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27001,402,1.02 [0.92-1.14],0.6666529321028227
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27396,66,0.98 [0.74-1.29],0.8681210061512498
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27759,55,1.05 [0.78-1.42],0.7388539953297583
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26692,93,0.96 [0.76-1.21],0.74374514229287
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26755,156,0.97 [0.81-1.16],0.7033847552596744
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26640,111,1.06 [0.86-1.31],0.5994612181631283
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,26903,72,1.01 [0.78-1.31],0.9454823268661584
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26591,62,0.71 [0.53-0.94],0.0192048693192036
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27091,122,0.96 [0.79-1.18],0.7157124036137793
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27152,183,1.05 [0.89-1.24],0.573318364402146
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26736,137,1.06 [0.88-1.28],0.5432518823503171
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26629,100,1.10 [0.89-1.37],0.3828238522735713
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26606,77,1.21 [0.95-1.55],0.1287933530273541
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25559,2135,1.01 [0.96-1.06],0.609896576597639
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26682,83,0.97 [0.76-1.24],0.8073864482979722
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27516,433,0.96 [0.86-1.07],0.4343694965239149
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27132,49,0.84 [0.60-1.16],0.276377513385356
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27255,172,1.11 [0.94-1.32],0.2050576959594816
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27553,116,0.89 [0.72-1.09],0.2585029747271865
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27744,117,0.98 [0.80-1.21],0.868748007748797
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27661,143,1.04 [0.87-1.25],0.6532779948569357
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27507,70,1.02 [0.79-1.34],0.8579154775947919
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,27505,68,0.93 [0.71-1.22],0.5828606371118488
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27686,826,1.00 [0.93-1.08],0.9886951870635362
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27429,569,1.04 [0.95-1.14],0.4025338180460771
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,26982,122,0.90 [0.73-1.10],0.2983927762088036
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,26944,84,1.03 [0.81-1.31],0.8113798309391722
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,27514,85,0.78 [0.61-1.00],0.0512107558674164
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27665,236,0.86 [0.74-1.00],0.0461203492713116
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27495,66,0.96 [0.73-1.26],0.7466572434364932
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,All influenza,26044,131,1.00 [0.83-1.22],0.9616837734774624
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26042,129,1.01 [0.83-1.23],0.8887633233792837
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19733,126,1.18 [0.97-1.43],0.0914646123133863
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,27634,292,1.14 [1.00-1.29],0.0499214336382363
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21509,2094,1.08 [1.03-1.13],0.0025366198687473
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21677,2070,1.08 [1.03-1.13],0.0019688035350901
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27363,126,1.15 [0.95-1.40],0.1567142320110748
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",25980,67,1.27 [0.98-1.66],0.0709583249021612
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Bronchiectasis,24023,416,1.24 [1.11-1.37],0.000100085842165
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23679,72,1.08 [0.83-1.40],0.5655029771203348
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26614,3007,1.07 [1.03-1.11],0.0012005811986358
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26497,63,0.89 [0.67-1.18],0.4141444746622629
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26581,147,1.18 [0.99-1.41],0.0642889079444464
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27614,1073,1.05 [0.99-1.13],0.1221294499015201
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26505,71,1.21 [0.94-1.57],0.140645009602966
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25667,5227,1.08 [1.04-1.11],2.189971093596543e-06
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26766,332,1.09 [0.97-1.23],0.1446844230853255
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Early onset COPD,26861,320,1.06 [0.94-1.20],0.3388899871640115
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Emphysema,23889,282,1.25 [1.10-1.42],0.0006466378142106
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26131,233,1.09 [0.94-1.26],0.243009993499132
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27592,1679,1.05 [1.00-1.11],0.0607887008329245
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26173,275,1.08 [0.95-1.24],0.2288147548753772
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Later onset COPD,26861,753,1.06 [0.98-1.15],0.1631079364678151
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27783,230,1.06 [0.92-1.23],0.4034921339121686
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Nasal polyp,26501,67,1.03 [0.79-1.35],0.8127884223884958
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27558,936,1.07 [0.99-1.15],0.0700328541672511
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,27597,1785,1.06 [1.01-1.12],0.026969341567804
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27228,794,1.14 [1.06-1.24],0.0006069833224012
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other pleural conditions,25848,36,0.90 [0.62-1.31],0.5844431873952162
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27708,352,1.07 [0.95-1.20],0.2603873765590745
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27699,1207,1.09 [1.02-1.16],0.0083363415722223
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural effusion,26674,862,1.06 [0.98-1.14],0.1408081155347548
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural plaque,25858,46,1.20 [0.87-1.65],0.27196678036934
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27352,1439,1.04 [0.99-1.11],0.1394111971710995
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27753,200,1.04 [0.89-1.22],0.5936995435759951
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pneumothorax,25905,93,1.12 [0.89-1.40],0.3427153530101466
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pollen allergy,27759,245,1.11 [0.96-1.27],0.1563976541586386
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,27422,66,1.06 [0.81-1.39],0.6744331140555097
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19660,53,1.31 [0.98-1.76],0.067996299745209
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27532,910,1.06 [0.99-1.14],0.1072382745485515
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26726,292,1.14 [1.00-1.29],0.0452811169127058
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Viral pneumonia,26133,220,1.07 [0.92-1.24],0.4040236985766372
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27376,173,1.02 [0.86-1.21],0.7865113532767034
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13417,107,1.17 [0.94-1.44],0.1575918466799728
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19809,39,0.95 [0.66-1.36],0.7827396182458999
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,27603,143,0.81 [0.67-0.98],0.0321612157353271
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute gastritis,20826,92,1.07 [0.85-1.35],0.561085325339265
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,25456,163,1.26 [1.07-1.49],0.0069706424781897
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute peritonitis,27210,89,1.29 [1.03-1.62],0.0283866472056559
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26889,35,1.12 [0.77-1.63],0.564557394953385
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,21079,345,1.06 [0.94-1.19],0.3348645717391943
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25375,82,1.41 [1.11-1.78],0.0041661163370774
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27352,82,1.40 [1.11-1.78],0.0047965452006549
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholecystitis,25482,189,1.08 [0.92-1.26],0.3738319160726675
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,26489,1196,1.05 [0.98-1.12],0.1502747147564893
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,21084,350,1.15 [1.03-1.30],0.0167564786375645
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25333,40,1.25 [0.89-1.76],0.2014343902600498
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27705,76,1.06 [0.82-1.37],0.6637523292586833
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Coeliac disease,26207,153,1.05 [0.88-1.26],0.5821735129081282
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Collagenous colitis,25868,113,0.98 [0.80-1.21],0.8604248108840269
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27649,153,1.09 [0.91-1.30],0.3559107719761999
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Constipation,27437,1758,1.01 [0.96-1.07],0.6822908378178044
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn disease,25849,94,1.10 [0.88-1.38],0.3961182572463755
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27422,70,1.14 [0.88-1.48],0.3179018554683379
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25853,98,1.08 [0.86-1.34],0.5158867716218349
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Dental caries,26958,231,1.11 [0.96-1.28],0.1547535518474787
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26139,2509,1.04 [0.99-1.08],0.1158834339114974
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,27646,186,0.93 [0.79-1.10],0.4089904823910728
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of liver,27687,833,1.08 [1.00-1.17],0.0405007366280983
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25444,4710,1.01 [0.98-1.04],0.5723689169349602
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27321,594,1.07 [0.97-1.17],0.1641791810092549
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27671,550,1.13 [1.03-1.24],0.0129121061282255
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26847,120,0.89 [0.73-1.09],0.2704232350658578
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26692,66,1.07 [0.81-1.40],0.6364464104457427
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27478,1424,1.02 [0.97-1.09],0.4092293810546177
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of tongue,26704,111,1.03 [0.83-1.26],0.8123936606518799
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26907,1614,1.07 [1.02-1.13],0.0112322127571381
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23028,3258,1.05 [1.01-1.09],0.0196047101612051
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,20867,133,1.08 [0.89-1.31],0.4352850517853578
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27739,112,1.04 [0.84-1.28],0.7280173857466181
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27687,65,1.39 [1.07-1.80],0.0147303262974895
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26952,98,1.07 [0.85-1.34],0.5590986400445713
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19884,114,1.21 [0.99-1.48],0.0605407702788293
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,21406,672,1.01 [0.93-1.10],0.7569198973450938
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,21090,356,1.00 [0.88-1.12],0.9491881802699346
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23584,2850,1.02 [0.98-1.07],0.2725826962944686
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21216,482,1.01 [0.91-1.12],0.8352008732750822
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21736,8574,1.03 [1.01-1.06],0.0121296977059308
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,GI-bleeding,27202,1148,1.01 [0.94-1.07],0.879943858680759
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26790,63,1.00 [0.75-1.32],0.9955852474894364
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20754,1278,1.08 [1.02-1.15],0.0145038076402751
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26895,41,1.02 [0.72-1.45],0.8991944736007051
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Hernia,26583,2953,1.02 [0.98-1.07],0.2537144175167276
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impacted teeth,27697,60,1.53 [1.17-2.00],0.0019522064935651
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impaction of intestines,19836,66,1.19 [0.91-1.56],0.1991912530072482
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,23800,170,0.91 [0.77-1.09],0.3059853226102183
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19874,104,1.02 [0.82-1.26],0.8731613852910473
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26234,180,1.07 [0.91-1.26],0.4427772796703205
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20598,828,1.06 [0.99-1.15],0.1147414107936989
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27773,367,1.22 [1.09-1.37],0.0005959403210535
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26583,828,1.10 [1.02-1.19],0.0122442466393245
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26870,1115,1.10 [1.03-1.17],0.0048778643593768
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20894,160,1.09 [0.91-1.30],0.3350067481442397
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophagitis,21311,577,1.02 [0.93-1.12],0.6179652978511765
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27741,155,1.02 [0.85-1.22],0.8184997735360804
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23692,62,1.04 [0.79-1.38],0.7682448410419069
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,21058,1288,1.03 [0.97-1.09],0.3809375337921715
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25602,309,1.10 [0.97-1.24],0.1510369188810171
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,25481,188,0.95 [0.81-1.12],0.5695841727432536
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,21381,1611,1.00 [0.95-1.06],0.9788289783983752
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,25584,5814,1.02 [0.99-1.05],0.1269140264995352
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26692,230,1.02 [0.88-1.18],0.7847999225256267
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,27556,702,1.08 [1.00-1.18],0.0577967155336314
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21330,596,1.03 [0.94-1.13],0.536279368084454
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25455,162,1.06 [0.89-1.26],0.5265847382044684
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27606,485,1.10 [0.99-1.21],0.0736438540848597
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21842,1108,0.99 [0.93-1.06],0.8201005057541761
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27221,1167,1.01 [0.95-1.08],0.7930988539611417
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26921,194,1.06 [0.91-1.24],0.4514485582077935
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21586,1816,1.02 [0.97-1.08],0.4254202208978864
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22884,2150,1.00 [0.95-1.05],0.8791689529915191
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26958,104,1.08 [0.87-1.34],0.4892916619721527
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26735,980,1.08 [1.01-1.16],0.0291203583070642
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20106,336,1.02 [0.91-1.16],0.7019038906738251
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27676,74,1.39 [1.09-1.77],0.0089852376851135
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20272,502,0.99 [0.90-1.09],0.8618904906416422
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26189,135,1.07 [0.88-1.29],0.4972279505979425
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27781,72,0.92 [0.71-1.20],0.5467662805344832
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26729,132,0.94 [0.77-1.14],0.511095055363195
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Toxic colitis,25823,68,0.95 [0.72-1.25],0.7104305262214159
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20971,237,1.13 [0.98-1.31],0.0835829481927601
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,25929,174,1.23 [1.04-1.44],0.014204578543145
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25898,143,1.22 [1.02-1.46],0.0326833063140167
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,23804,174,0.82 [0.69-0.98],0.0289122612126864
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,19963,193,1.03 [0.87-1.20],0.7553407891136279
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ventral hernia,23892,262,1.07 [0.93-1.23],0.3387623836640923
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Volvulus,19856,86,0.81 [0.64-1.04],0.1004002680086442
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27699,264,1.20 [1.05-1.37],0.0078847221849753
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27457,79,0.89 [0.69-1.15],0.3694147052689225
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25688,220,1.03 [0.89-1.20],0.6580674103999122
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27247,639,1.04 [0.95-1.13],0.3972078873708451
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26755,147,1.22 [1.02-1.46],0.0305084360455368
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25813,345,0.98 [0.87-1.11],0.7885604902692943
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27469,285,1.09 [0.96-1.24],0.1822463997051655
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27677,493,1.05 [0.95-1.16],0.3711977762142221
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27237,53,1.08 [0.80-1.46],0.6201658635121574
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26159,3225,1.03 [0.99-1.07],0.149172313748769
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27332,485,0.94 [0.85-1.04],0.225358360623592
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27179,332,0.99 [0.88-1.12],0.8554585711155325
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27465,857,1.05 [0.97-1.13],0.246537579036748
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27765,80,1.06 [0.83-1.36],0.6388456202039466
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25559,91,0.79 [0.62-1.00],0.0529306698502264
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26894,47,0.98 [0.71-1.36],0.9159381282247184
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27453,269,1.08 [0.95-1.24],0.2525553701242257
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25894,426,1.10 [0.99-1.22],0.0840827264856817
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,25516,48,1.07 [0.78-1.47],0.6941308781485461
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27684,83,0.85 [0.67-1.10],0.2157435479727181
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26770,162,1.16 [0.97-1.37],0.1002158035947765
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27550,172,0.76 [0.64-0.91],0.0021283734818384
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27242,58,1.06 [0.79-1.41],0.7148082958810975
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25535,67,1.08 [0.83-1.41],0.5761107026626997
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27093,1625,1.03 [0.98-1.09],0.2371310482214427
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25929,461,1.11 [1.00-1.22],0.0536486511752717
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25521,53,1.05 [0.78-1.43],0.7429641342281396
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27698,320,0.88 [0.77-0.99],0.0391431630673496
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27268,84,0.90 [0.70-1.15],0.3945222755569902
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27622,244,0.82 [0.71-0.95],0.0088064002582516
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27735,300,1.15 [1.02-1.31],0.0260275049816838
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25628,160,1.06 [0.89-1.26],0.5068700759460334
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25737,269,1.00 [0.87-1.14],0.9544313090840748
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27720,285,1.16 [1.02-1.32],0.0244248328204947
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25672,204,1.09 [0.94-1.28],0.2608598286909655
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27754,153,0.90 [0.75-1.08],0.2547687544170092
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23717,125,1.12 [0.92-1.36],0.2656966865188488
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25241,6487,1.02 [0.99-1.05],0.2328216997124482
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23823,5069,1.03 [1.00-1.06],0.0734440451269059
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23670,78,0.99 [0.77-1.27],0.922813661010368
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23821,155,1.04 [0.87-1.24],0.6455405051357879
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23880,214,1.05 [0.91-1.22],0.5008550053097915
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27496,114,0.84 [0.68-1.03],0.0986901310247969
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23784,118,0.94 [0.77-1.16],0.5929239459794416
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,20149,1395,1.02 [0.96-1.08],0.4916756402865962
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27637,223,1.07 [0.92-1.24],0.3568053365949926
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24282,616,1.04 [0.95-1.14],0.3616552136578376
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,23359,8234,1.01 [0.99-1.03],0.4481744741049417
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24908,141,1.06 [0.88-1.27],0.5684505714161002
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23725,133,1.09 [0.90-1.32],0.3577517864672775
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24291,699,1.03 [0.95-1.12],0.4749494419191228
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26760,3094,1.03 [0.99-1.08],0.1055236575389048
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23770,178,0.97 [0.82-1.15],0.7459196485159332
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,23983,391,1.19 [1.06-1.33],0.0021319642535912
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23769,177,1.17 [0.99-1.38],0.0619066351821114
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26822,109,0.90 [0.73-1.12],0.3666338049074097
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20675,1921,1.03 [0.98-1.08],0.2417331956077263
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18987,233,1.19 [1.03-1.38],0.0170810826194971
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27776,230,1.15 [0.99-1.33],0.0583951551442975
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18854,100,1.33 [1.08-1.65],0.0086596310984895
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19334,580,0.96 [0.87-1.05],0.3431951423460193
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23927,335,0.96 [0.85-1.09],0.5407417259177012
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19405,651,0.98 [0.90-1.07],0.6342022026284755
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23735,69,1.17 [0.90-1.52],0.2488362100845633
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24395,729,1.11 [1.02-1.20],0.0135815010307046
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24007,341,1.13 [1.00-1.27],0.0462109742269349
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19363,609,0.99 [0.90-1.08],0.7598640466753505
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23687,95,1.23 [0.99-1.54],0.0653764222597064
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23661,69,1.18 [0.91-1.53],0.2216524012977682
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24818,51,1.16 [0.86-1.58],0.3366373679568726
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27301,2534,1.01 [0.96-1.05],0.7898538507932947
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26585,1818,1.01 [0.96-1.06],0.7032782913073182
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27589,610,1.09 [1.00-1.20],0.048486390981809
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21834,3080,1.04 [1.00-1.08],0.0615123218076333
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18829,75,0.94 [0.72-1.21],0.6118939408816575
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23697,105,1.23 [1.00-1.52],0.0521949325033096
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18798,44,0.96 [0.68-1.35],0.8291555880529375
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18961,207,1.04 [0.89-1.21],0.6176352851911153
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25058,291,0.91 [0.79-1.04],0.1478680140872569
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,25365,598,1.02 [0.93-1.12],0.6406922576252039
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27759,113,1.04 [0.84-1.28],0.7401649394383356
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25758,2092,1.05 [1.00-1.10],0.0386867864189903
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23726,134,0.99 [0.81-1.20],0.8920520566814479
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18987,233,0.91 [0.78-1.05],0.1928563879039445
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24499,833,1.06 [0.98-1.14],0.147377284957198
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,21342,2588,1.01 [0.97-1.06],0.5403590095301907
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26848,135,0.89 [0.73-1.08],0.2407661496403155
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27769,78,0.97 [0.75-1.25],0.8004956984897652
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23675,83,1.13 [0.89-1.44],0.3132547399022808
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25100,1508,1.06 [1.00-1.12],0.0495295422731207
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23675,83,1.11 [0.87-1.41],0.403722827737032
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20793,2039,1.05 [1.00-1.11],0.0331643863483137
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24904,137,0.94 [0.78-1.14],0.5593674043391047
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23655,63,0.97 [0.73-1.28],0.8206706493548965
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,23870,204,0.93 [0.80-1.09],0.3942121527365044
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24190,598,1.01 [0.92-1.11],0.8358153548153536
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27229,516,1.17 [1.06-1.28],0.0018429573941362
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24334,668,1.02 [0.94-1.12],0.5892545697120857
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27604,590,1.11 [1.02-1.22],0.0194117820504928
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27761,70,1.21 [0.94-1.57],0.1418742461887595
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23819,227,0.94 [0.81-1.09],0.3874683380285033
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21313,935,1.05 [0.98-1.13],0.1665153634886586
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24272,680,1.03 [0.94-1.12],0.5193359097264993
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23716,124,1.04 [0.86-1.27],0.6749789462462338
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18832,78,0.94 [0.73-1.21],0.6383793645184095
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21458,2704,1.05 [1.01-1.10],0.0209652376977504
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19614,860,1.04 [0.97-1.12],0.2889560817563257
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27017,304,1.17 [1.03-1.33],0.0136504897089118
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27731,85,0.94 [0.74-1.20],0.6405623985287479
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",25438,55,1.10 [0.81-1.48],0.5505097455396766
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18833,79,0.96 [0.74-1.23],0.7294460292625093
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23781,115,1.06 [0.86-1.30],0.571779164676
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19369,615,1.10 [1.01-1.20],0.03700972910351
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23933,341,0.91 [0.81-1.03],0.1438982080867987
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23958,292,1.15 [1.02-1.31],0.0285742879353107
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,23947,281,1.04 [0.91-1.19],0.5676004348404782
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21431,86,1.22 [0.97-1.54],0.0940777537620793
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27768,77,1.09 [0.85-1.40],0.4857996181083412
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24238,646,0.99 [0.91-1.09],0.9097652605530469
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],26875,162,1.14 [0.96-1.35],0.13460040624951
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26449,2857,1.04 [0.99-1.08],0.0995765149177452
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23746,154,0.85 [0.71-1.02],0.0824871526284997
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24249,583,1.09 [0.99-1.19],0.0639869156965571
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26039,270,0.90 [0.78-1.03],0.1146626807868694
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,23951,285,1.05 [0.92-1.19],0.4873420400084052
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25462,1796,1.02 [0.96-1.07],0.5677229336141723
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24890,1224,1.02 [0.96-1.09],0.467079751622255
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23659,67,1.15 [0.88-1.51],0.2967354630749743
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26942,229,0.97 [0.84-1.13],0.7262889476439051
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23796,204,1.01 [0.87-1.18],0.8588968865668816
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23720,128,0.87 [0.72-1.07],0.1906598194792174
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18810,56,1.37 [1.03-1.83],0.0323704003101452
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26690,1282,1.09 [1.02-1.16],0.0065012663457908
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20801,102,1.09 [0.88-1.35],0.448928506517075
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27078,109,0.90 [0.72-1.11],0.3235151609925511
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27626,238,1.19 [1.03-1.37],0.0156542860359842
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27415,27,0.72 [0.46-1.12],0.1445444780220211
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26924,1516,1.07 [1.01-1.13],0.0270418653914963
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27613,80,1.12 [0.88-1.44],0.363888610780724
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27573,247,1.05 [0.91-1.20],0.5396438385705492
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,24502,255,1.03 [0.90-1.18],0.6895769349368653
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Dialysis,25465,57,1.61 [1.22-2.11],0.0007038309030736
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27310,341,0.98 [0.87-1.11],0.7895556524336822
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20882,183,1.01 [0.86-1.19],0.8900228446690437
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21097,398,0.88 [0.79-0.99],0.0315819742541817
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21708,1009,1.01 [0.94-1.08],0.8275180157117245
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21619,5136,1.02 [0.99-1.05],0.2073841805122182
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27599,66,1.25 [0.96-1.63],0.0954551433376823
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,25287,217,0.94 [0.81-1.10],0.4601341638927291
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27227,405,1.00 [0.89-1.11],0.9426734299695056
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27317,130,0.75 [0.62-0.92],0.0052801047632232
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21003,304,0.99 [0.87-1.13],0.8893251718922868
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24327,80,1.12 [0.88-1.43],0.3683453134190542
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23179,2480,0.98 [0.94-1.03],0.4244871237243293
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20845,146,1.09 [0.91-1.31],0.3531600827859018
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27775,67,1.18 [0.91-1.54],0.2186069067946185
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27779,76,0.96 [0.74-1.24],0.7285679596225116
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26531,2284,1.02 [0.97-1.07],0.3763710787941675
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24731,484,1.01 [0.91-1.12],0.8736601776058592
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27089,120,1.02 [0.83-1.25],0.851290715727046
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27723,397,1.12 [1.00-1.25],0.0419573515456421
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27726,93,1.04 [0.83-1.31],0.7068687895297785
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26207,1960,1.02 [0.97-1.08],0.3649940266799374
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27032,210,1.06 [0.91-1.23],0.4875134925838084
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20854,155,1.24 [1.04-1.48],0.014358291373295
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21071,372,0.95 [0.84-1.06],0.3562483384107399
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20814,115,1.08 [0.88-1.32],0.4713097724703536
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20909,210,1.04 [0.90-1.22],0.573095379993215
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25338,268,0.98 [0.85-1.12],0.7193568172871738
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27456,130,1.25 [1.04-1.51],0.0200654037460021
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21013,314,1.06 [0.93-1.19],0.3948484536114319
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20807,108,0.93 [0.75-1.16],0.5275494130913632
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21355,656,0.99 [0.90-1.08],0.7602745844538343
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20863,164,1.13 [0.96-1.34],0.1491664853258992
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21299,600,1.03 [0.94-1.13],0.5045285092404994
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27571,38,1.06 [0.74-1.51],0.7618951143095994
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27586,2516,1.06 [1.01-1.10],0.0165745317526064
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",25236,166,1.11 [0.94-1.31],0.233106470300439
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25515,107,1.07 [0.87-1.33],0.5176847150392037
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27422,34,0.91 [0.62-1.34],0.6421747030607907
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24397,150,1.20 [1.01-1.43],0.0430287942092527
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27658,270,1.13 [0.99-1.29],0.0746835417067002
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20843,144,1.12 [0.93-1.34],0.2200406888768213
